Loading
Novasign
Novasign optimizes bioprocess development by reducing experiment effort by up to 70% using their unique SaaS approach. This approach increases production process robustness and products enter the market earlier.
Funding
Every round, secondary, debt facility or acquisition involving Novasign that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log in